|
Mandaglio-Collados D, Ruiz-Alcaraz AJ, Rivera-Caravaca JM, Ramos-Bratos MP, Marin F, Lopez-Galvez R. Analysis of key proinflammatory mechanisms in cardiovascular pathology through stimulation with lipopolysaccharide and urban particulate matter in mouse atrial cardiomyocytes. Environ Toxicol Pharmacol. 2025 Feb 9;114:104652. doi: 10.1016/j.etap.2025.104652. Online ahead of print. PubMed PMID: 39933631.
AÑO: 2025; IF: 4.2
|
39933631
|
Soler-Espejo E, Chen Y, Rivera-Caravaca JM, Sanchez-Salas JA, Esteve-Pastor MA, Marin F, Roldan V, Lip GYH. Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort. Diabetes Obes Metab. 2025 Dec 4. doi: 10.1111/dom.70335. Online ahead of print. PubMed PMID: 41342100.
AÑO: 2025; IF: 5.7
|
|
Lopez-Galvez R, Orenes-Pinero E, Rivera-Caravaca JM, Perez-Sanz F, Ramos-Bratos MP, Roca MI, Mandaglio-Collados D, Lopez-Garcia C, Gil-Perez P, Esteve-Pastor MA, Marin F. Microbial Insights: The Role of Diet in Modulating Gut Microbiota and Metabolites After Acute Coronary Syndrome. Mol Nutr Food Res. 2025 Apr 22:e70046. doi: 10.1002/mnfr.70046. Online ahead of print. PubMed PMID: 40260991.
AÑO: 2025; IF: 4.2
|
|
Soler-Espejo E, Chen Y, Roldan V, Marin F, Rivera-Caravaca JM, Lip GYH. Prognostic value of adiposity indices in anticoagulated patients with atrial fibrillation: The prospective Murcia AF Project III cohort. Am J Clin Nutr. 2025 Dec 30:101184. doi: 10.1016/j.ajcnut.2025.101184. Online ahead of print. PubMed PMID: 41478434.
AÑO: 2025; IF: 6.9
|
|
Soler-Espejo E, Ramos-Bratos MP, Gonzalez-Lozano E, Lip GYH, Marin F, Rivera-Caravaca JM, Roldan V. Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation. Eur J Prev Cardiol. 2025 May 14:zwaf287. doi: 10.1093/eurjpc/zwaf287. Online ahead of print. PubMed PMID: 40366897.
AÑO: 2025; IF: 7.5
|